BlackRock Investment Management, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 50 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$5,0000.0%4,8370.0%0.00%
Q3 2016$5,000
-28.6%
4,8370.0%0.00%
Q2 2016$7,000
+40.0%
4,837
+39.0%
0.00%
Q1 2016$5,000
-16.7%
3,4790.0%0.00%
Q4 2015$6,000
-14.3%
3,479
+12.4%
0.00%
Q3 2015$7,000
-12.5%
3,0960.0%0.00%
Q2 2015$8,000
-95.6%
3,096
-94.3%
0.00%
Q1 2015$182,000
-2.2%
54,225
+1.0%
0.00%
Q4 2014$186,000
-30.9%
53,695
+0.5%
0.00%
Q3 2014$269,000
-62.4%
53,413
+3.0%
0.00%
-100.0%
Q2 2014$716,00051,8740.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders